Gary L. Myers, PhD, FACB
2008 AACC Past President’s Award

Dr. Myers is chief of the clinical chemistry branch at the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga. He also serves as the scientific director of the World Health Organization Collaborating Center for Reference and Research in Blood Lipids at the CDC. His 30-year career at the CDC has focused on improving the laboratory measurement of biochemical markers used to assess chronic disease risk, particularly cardiovascular disease. Dr. Myers has served the AACC at all levels, including chair of the Lipids and Lipoproteins Division, 2002 Annual Meeting Organizing Committee, and 2006 Beckman Conference. He has served on the Meetings Management Group, Nominating Committee, and Board of Directors. Under his leadership, 2007 was an exciting and busy year for the AACC as it made progress in all of its strategic initiatives. It was also a transitional year, as Dr. Myers directed the search for a new editor-in-chief for AACC’s flagship journal, Clinical Chemistry. It was a special year for the website Lab Tests Online, which expanded into six new countries, including Australia, Germany, Hungary, Italy, Poland, and Spain. Lab Tests Online is recognized as the premier online source for information about laboratory testing. The Personalized Medicine Advisory Group was formed to recommend how the AACC should embrace and become active in this rapidly expanding area. Another important initiative was partnering with the Association for Molecular Pathology to develop and offer a molecular pathology review course in 2008.

2006 Award for Outstanding Contributions Through Service to the Profession of Clinical Chemistry

Dr. Myers is chief of the clinical chemistry branch at the Centers for Disease Control and Prevention in Atlanta. He also serves as the scientific director of the World Health Organization Collaborating Center for Reference and Research in Blood Lipids at the CDC.

His 30-year career at the CDC has focused on improving the laboratory measurement of biochemical markers used to assess chronic disease risk, particularly cardiovascular disease. As the CDC’s representative on the National Cholesterol Education Program’s Laboratory Standardization Panel, he played a pivotal role in developing national guidelines to improve the reliability of cholesterol testing. He organized the Cholesterol Reference Method Laboratory Network, which has been a model for other such efforts.

Dr. Myers has served the AACC at all levels. He is currently president-elect and recently completed a three-year term on the board of directors. He chaired the Lipids and Lipoproteins Division, which presented him the Gerald R. Cooper Award for Outstanding Service. He chaired the 2002 Annual Meeting Organizing Committee and the 2006 Beckman Conference.

Dr. Myers has served on many AACC committees. He chairs the National Academy of Clinical Biochemistry’s Committee for a Laboratory Medicine Practice Guideline for Emerging Cardiac Markers and is involved with various other national and international organizations dealing with laboratory measurement and standardization issues.

He serves on the National Kidney Disease Education Program’s Laboratory Working Group, the American Diabetes Association’s Insulin Standardization Working Group, the International Federation of Clinical Chemistry’s Working Group on Hemoglobin A1c Standardization, and the National Institutes of Health’s C-peptide Standardization Committee.

Dr. Myers also serves on the board of the Clinical and Laboratory Standards Institute and chairs its Global Advisory Committee. He has published more than 80 articles, book chapters, and editorials.

Page Access: